• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Mountain Crest Acquisition Corp. II

    8/9/21 10:44:14 AM ET
    $MCAD
    Finance
    Get the next $MCAD alert in real time by email
    SC 13G 1 lf_sc13g.htm SCHEDULE 13G Schedule 13G

     

    OMB APPROVAL

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    OMB Number:3235-0145 

    Expires:Febuary 28, 2009 

    Estimated average burden
    hours per response ....10.4

     

     

    SCHEDULE 13G

    Under the Securities and Exchange Act of 1934

    (Amendment No.                 )*

     

    Mountain Crest Acquisition Corp. II

    (Name of Issuer)

     

    common stock, $0.0001 par value

    (Title of Class of Securities)

     

    62402D204

    (CUSIP Number)

     

     

    August 6, 2021

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    o  Rule 13d-1(b)

    ý  Rule 13d-1(c)

    o  Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    1


     

    CUSIP No.   62402D204

    1.Names of Reporting Persons. 

    I.R.S. Identification Nos. of above persons (entities only). 

    Feis Equities LLC 

    2.Check the Appropriate Box if a Member of a Group 

    (a)o 

    (b)o 

    3.SEC Use Only 

    4.Citizenship or Place of OrganizationState of Illinois 

    Number of Shares Beneficially Owned by Each Reporting Person With

    5.Sole Voting Power532,762 

    6.Shared Voting Power                               0 

    7.Sole Dispositive Power532,762 

    8.Shared Dispositive Power                        0 

    9.Aggregate Amount Beneficially Owned by Each Reporting Person 

    532,762 

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)      o 

    11.Percent of Class Represented by Amount in Row (9) 

    7.05% 

    12.Type of Reporting Person (See Instructions) 

    OO-Limited Liability Company 


    2


     

    CUSIP No. 62402D204

    1.Names of Reporting Persons. 

    I.R.S. Identification Nos. of above persons (entities only). 

    Lawrence M. Feis 

    2.Check the Appropriate Box if a Member of a Group 

    (a)o 

    (b)o 

    3.SEC Use Only 

    4.Citizenship or Place of OrganizationU.S.A. 

    Number of Shares Beneficially Owned by Each Reporting Person With

    5.Sole Voting Power532,762 

    6.Shared Voting Power                              0 

    7.Sole Dispositive Power532,762 

    8.Shared Dispositive Power                        0 

    9.Aggregate Amount Beneficially Owned by Each Reporting Person 

    532,762 

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)      o 

    11.Percent of Class Represented by Amount in Row (9)  

    7.05% 

    12.Type of Reporting Person (See Instructions) 

    IN 


    3


     

    Item 1.

    The name and address of the principal executive offices of the Issuer are:

    Mountain Crest Acquisition Corp. II

    311 West 43rd Street, 12th Floor

    New York, NY  10036

    Item 2.

    This statement on Schedule 13G is being filed by:

    (a) Name of Person Filing 

     

    (i)Feis Equities LLC 

    (ii)Lawrence M. Feis 

     

     

     

     

     

    (b)Address: 

    The address of the business office of each of the Reporting Persons is:

     

    20 North Wacker Drive

    Suite 2115

    Chicago, Illinois  60606

     

     

     

     

     

    (c)Citizenship/Place: 

    Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated hereto by reference for each Reporting Person.

     

    (d)Title of Class of Securities: 

    common stock, $0.0001 par value

     

    (e)CUSIP Number: 

     

     

     

    62402D204

     

     


    4


    Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a)oBroker or dealer registered under section 15 of the Act (15 U.S.C. 78o). 

    (b)oBank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). 

    (c)oInsurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). 

    (d)oInvestment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). 

    (e)oAn investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); 

    (f)oAn employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); 

    (g)oA parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); 

    (h)oA savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); 

    (i)oA church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); 

    (j)oGroup, in accordance with §240.13d-1(b)(1)(ii)(J). 

    Item 4.  Ownership

     

    The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for each Reporting Person and incorporated by reference herein.

     

    The percentage set forth in row 11 of the cover page for each Reporting Person is based on 7,557,500 shares of common stock outstanding as of June 25, 2021, as reported by the Issuer in its Quarterly Report on Form 10-Q/A for the quarter ended March 31, 2021, filed with the Securities and Exchange Commission on June 28, 2021.


    5


     

    Item 5.  Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  o

    Item 6.  Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

    Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

    Not applicable.

    Item 8.  Identification and Classification of Members of the Group

    Not applicable.

    Item 9.  Notice of Dissolution of Group

    Not applicable.

    Item 10.  Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    6


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date:August 9, 2021 

     

     

     

     

    Date:August 9, 2021 

     

    FEIS EQUITIES LLC

    By:/s/ Lawrence M. Feis 

                Managing Member LLC

     

     

    LAWRENCE M. FEIS

    By:/s/ Lawrence M. Feis 

     


    7


     

     

    EXHIBIT INDEX

     

    Ex.

     

    Page No.

     

     

     

    A

    Joint Filing Agreement

    9


    8


     

    JOINT FILING AGREEMENT

     

    The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of Mountain Crest Acquisition Corp. II dated as of August 9,2021 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

     

    FEIS EQUITIES LLC 

    By:/s/ Lawrence M. Feis 

    Managing Member LLC 

     

     

    LAWRENCE M. FEIS 

    By:/s/ Lawrence M. Feis 

     

    Date:  August 9, 2021


    9

    Get the next $MCAD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MCAD

    DatePrice TargetRatingAnalyst
    7/29/2021$19.00Buy
    Lake Street
    More analyst ratings

    $MCAD
    SEC Filings

    See more
    • Mountain Crest Acquisition Corp. II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status

      8-K - Better Therapeutics, Inc. (0001832415) (Filer)

      11/3/21 5:26:13 PM ET
      $MCAD
      Finance
    • SEC Form 25-NSE filed by Mountain Crest Acquisition Corp. II

      25-NSE - Mountain Crest Acquisition Corp II (0001832415) (Subject)

      10/28/21 4:10:53 PM ET
      $MCAD
      Finance
    • SEC Form 425 filed by Mountain Crest Acquisition Corp. II

      425 - Mountain Crest Acquisition Corp II (0001832415) (Subject)

      10/27/21 5:21:36 PM ET
      $MCAD
      Finance

    $MCAD
    Leadership Updates

    Live Leadership Updates

    See more
    • Better Therapeutics Appoints Dr. Risa Lavizzo-Mourey to its Board of Directors

      Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Dr. Risa Lavizzo-Mourey to its board of directors; she will also serve as Compensation Committee chair. "Dr. Lavizzo-Mourey brings critical insights into health policy, as well as her background as a primary care physician at a critical juncture for Better Therapeutics," said David Perry, co-founder and chairman of Better Therapeutics. "Her experience and counsel will help us establish our prescription digital therapeutics as the new standard of care for people with cardiometabolic diseases.

      4/20/21 8:00:00 AM ET
      $MRK
      $GE
      $INTC
      $MCAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Consumer Electronics/Appliances
      Technology

    $MCAD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $MCAD
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MCAD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $MCAD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form 3: New insider Heinen Mark claimed ownership of 6,667 shares

      3 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:35:22 PM ET
      $MCAD
      Finance
    • SEC Form 4: Perry David P bought $2,512,432 worth of shares (251,536 units at $9.99) and was granted 10,578,501 shares

      4 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:55:45 PM ET
      $MCAD
      Finance
    • SEC Form 3: New insider Parker Geoffrey M. claimed ownership of 33,333 shares

      3 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:30:59 PM ET
      $MCAD
      Finance
    • Better Therapeutics Closes Business Combination and Debuts on Nasdaq

      Trading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTX Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly traded special purpose acquisition corporation or SPAC. The resulting combined company will commence trading its shares on Nasdaq under the ticker symbol "BTTX" on October 29, 2021. The shareholders of Mountain Crest Acquisition Corp II approved the transaction at a special meeting held on October

      10/29/21 8:00:00 AM ET
      $MCAD
      Finance
    • Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.

      NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD) (the "Company"), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to approve its proposed business combination (the "business combination") with Better Therapeutics Inc. ("Better Therapeutics"), a company engaged in developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The business combination is expected to close on October 28, 2021, subject to the satisfaction of certain customary closing conditions. As part of the consummation o

      10/27/21 4:44:29 PM ET
      $MCAD
      Finance
    • Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021

      NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that MCAD's registration statement on Form S-4 (File No. 333-255493) relating to the previously announced merger of MCAD and Better Therapeutics has been declared effective by the U.S. Securities and Exchange Commission as of October 12, 2021. MCAD also announced that it will hold its special m

      10/12/21 8:00:04 PM ET
      $MCAD
      Finance
    • Lake Street initiated coverage on Mountain Crest Acquisition Corp. II with a new price target

      Lake Street initiated coverage of Mountain Crest Acquisition Corp. II with a rating of Buy and set a new price target of $19.00

      7/29/21 9:53:58 AM ET
      $MCAD
      Finance
    • SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II

      SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 5:28:53 PM ET
      $MCAD
      Finance
    • SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II

      SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 5:26:04 PM ET
      $MCAD
      Finance
    • SEC Form SC 13G filed by Mountain Crest Acquisition Corp. II

      SC 13G - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 1:11:00 PM ET
      $MCAD
      Finance